Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease
- 30 January 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 339 (2) , 172-174
- https://doi.org/10.1016/s0304-3940(02)01481-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophyPsychiatry Research, 2003
- CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjectsNeurology, 2002
- Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231Archives of Neurology, 2002
- Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231Annals of Neurology, 2001
- CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodiesNeurological Sciences, 2001
- CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's DiseaseMolecular Neurobiology, 2001
- CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective StudyExperimental Neurology, 2000
- Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sampleNeurology, 1999
- Vascular dementiaNeurology, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984